Global changes in gene expression during cardiac hypertrophy: A new direction of cardiac signaling research

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 2, 2006, Pages 219-222

  Usui, Soichiro ^a   Yeh, Ijen ^a   Tian, Bin ^a   Sadoshima, Junichi ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CYCLOHEXIMIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TRANSCRIPTION FACTOR;

DNA MICROARRAY; EDITORIAL; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE EXPRESSION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; LIGAND BINDING; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BIOMEDICAL RESEARCH; CARDIOMEGALY; CELLS, CULTURED; ENDOTHELIN-1; ENZYME INHIBITORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART VENTRICLES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCYTES, CARDIAC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; SIGNAL TRANSDUCTION;

EID: 33746214582     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.05.006     Document Type: Editorial

References (27)

1. Morisco C., Sadoshima J., Trimarco B., Arora R., Vatner D.E., and Vatner S.F. Is treating cardiac hypertrophy salutary or detrimental: the two faces of Janus. Am J Physiol, Heart Circ Physiol 284 (2003) H1043-H1047
2. Ito H., Hirata Y., Adachi S., Tanaka M., Tsujino M., Koike A., et al. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 92 (1993) 398-403
3. Sakai S., Miyauchi T., Kobayashi M., Yamaguchi I., Goto K., and Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 384 (1996) 353-355
4. Shohet R.V., Kisanuki Y.Y., Zhao X.S., Siddiquee Z., Franco F., and Yanagisawa M. Mice with cardiomyocyte-specific disruption of the endothelin-1 gene are resistant to hyperthyroid cardiac hypertrophy. Proc Natl Acad Sci U S A 101 (2004) 2088-2093
5. Kedzierski R.M., Grayburn P.A., Kisanuki Y.Y., Williams C.S., Hammer R.E., Richardson J.A., et al. Cardiomyocyte-specific endothelin A receptor knockout mice have normal cardiac function and an unaltered hypertrophic response to angiotensin II and isoproterenol. Mol Cell Biol 23 (2003) 8226-8232
6. Sugden P.H. An overview of endothelin signaling in the cardiac myocyte. J Mol Cell Cardiol 35 (2003) 871-886
7. Clerk A., Michael A., and Sugden P.H. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy?. J Cell Biol 142 (1998) 523-535
8. Clerk A., Kemp T.J., Harrison J.G., Mullen A.J., Barton P.J., and Sugden P.H. Up-regulation of c-jun mRNA in cardiac myocytes requires the extracellular signal-regulated kinase cascade, but c-Jun N-terminal kinases are required for efficient up-regulation of c-Jun protein. Biochem J 368 (2002) 101-110
9. Harrison J.G., Sugden P.H., and Clerk A. Endothelin-1 promotes phosphorylation of CREB transcription factor in primary cultures of neonatal rat cardiac myocytes: implications for the regulation of c-jun expression. Biochim Biophys Acta 1644 (2004) 17-25
10. Kennedy RA, Kemp TJ, Sugden PH, Clerk A. Using U0126 to dissect the role of the extracellular signal-regulated kinase 1/2/(ERK1/2) cascade in the regulation of gene expression by endothelin-1 in cardiac myocytes. J Mol Cell Cardiol 2006 (this issue). doi:10.1016/j.yjmcc.2006.04.011
11. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98 (2001) 5116-5121
12. Bueno O.F., De Windt L.J., Tymitz K.M., Witt S.A., Kimball T.R., Klevitsky R., et al. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 19 (2000) 6341-6350
13. Kakita T., Hasegawa K., Iwai-Kanai E., Adachi S., Morimoto T., Wada H., et al. Calcineurin pathway is required for endothelin-1-mediated protection against oxidant stress-induced apoptosis in cardiac myocytes. Circ Res 88 (2001) 1239-1246
14. Tokudome T., Horio T., Fukunaga M., Okumura H., Hino J., Mori K., et al. Ventricular nonmyocytes inhibit doxorubicin-induced myocyte apoptosis: involvement of endogenous endothelin-1 as a paracrine factor. Endocrinology 145 (2004) 2458-2466
15. Teerlink J.R., McMurray J.J., Bourge R.C., Cleland J.G., Cotter G., Jondeau G., et al. Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS). Am Heart J 150 (2005) 46-53
16. Robu V.G., Pfeiffer E.S., Robia S.L., Balijepalli R.C., Pi Y., Kamp T.J., et al. Localization of functional endothelin receptor signaling complexes in cardiac transverse tubules. J Biol Chem 278 (2003) 48154-48161
17. Pruitt K.D., and Maglott D.R. RefSeq and LocusLink: NCBI gene-centered resources. Nucleic Acids Res 29 (2001) 137-140
18. Nebert D.W., and Gielen J.E. Genetic regulation of aryl hydrocarbon hydroxylase induction in the mouse. Fed Proc 31 (1972) 1315-1325
19. Chang C.Y., and Puga A. Constitutive activation of the aromatic hydrocarbon receptor. Mol Cell Biol 18 (1998) 525-535
20. Andrieux L., Langouet S., Fautrel A., Ezan F., Krauser J.A., Savouret J.F., et al. Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes. Mol Pharmacol 65 (2004) 934-943
21. Lund A.K., Goens M.B., Nunez B.A., and Walker M.K. Characterizing the role of endothelin-1 in the progression of cardiac hypertrophy in aryl hydrocarbon receptor (AhR) null mice. Toxicol Appl Pharmacol 212 (2006) 127-135
22. Vasquez A., Atallah-Yunes N., Smith F.C., You X., Chase S.E., Silverstone A.E., et al. A role for the aryl hydrocarbon receptor in cardiac physiology and function as demonstrated by AhR knockout mice. Cardiovasc Toxicol 3 (2003) 153-163
23. Sadoshima J. Novel AT(1) receptor-independent functions of losartan. Circ Res 90 (2002) 754-756
24. Harada K., Komuro I., Shiojima I., Hayashi D., Kudoh S., Mizuno T., et al. Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knock out mice. Circulation 97 (1998) 1952-1959
25. Ishikawa Y., Sorota S., Kiuchi K., Shannon R.P., Komamura K., Katsushika S., et al. Downregulation of adenylylcyclase types V and VI mRNA levels in pacing-induced heart failure in dogs. J Clin Invest 93 (1994) 2224-2229
26. Bogoyevitch M.A., Glennon P.E., Andersson M.B., Clerk A., Lazou A., Marshall C.J., et al. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J Biol Chem 269 (1994) 1110-1119
27. Bogoyevitch M.A., Ketterman A.J., and Sugden P.H. Cellular stress differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes. J Biol Chem 270 (1995) 29710-29717